Contributing an Abstract to CASD
Abstracts may be submitted for consideration in a contributed/technical or clinical session. Descriptions of both session types are given below. To submit a paper for consideration, please send the following information by September 5 to Alyson Wilson, firstname.lastname@example.org.
1. Title of paper and a brief abstract
2. Name of author(s) and exact title of the organization(s).
3. Type of paper (technical or clinical).
4. Telephone number of the author(s).
5. E-mail address of the author(s).
Speakers will be notified regarding paper acceptance on a rolling basis, but no later than September 12.
Contributed/technical papers can vary in content from new research to well-posed problems in which statistical methods are applied to solve specific defense problems. Speakers are strongly encouraged to present their papers in terms of the potential or real problems that motivated the work. Where the solution to a problem relies on relatively recent or specialized results in the theory of statistics and probability, these results should be explained or documented in sufficient detail to permit an audience of statistical practitioners with broadly varying backgrounds to utilize the results to enhance their problem solving capabilities.
A distinct feature of this conference is the Clinical Session. Presentations feature applied statistics problems which have not been completely or satisfactorily solved, and for which the presenter seeks assistance in developing a satisfactory approach. A panel of experts, composed of invited speakers and other distinguished attendees, convenes for each clinical session to provide guidance. Authors of a clinical paper must provide a description of the problem by September 19 so that the panelists have sufficient time to prepare their recommendations. We invite you to consider this opportunity to present an interesting statistical problem to some of the country's leading applied and mathematical statisticians.
Technical papers are nominally allowed 30 minutes, to include 5 minutes at the end for audience discussion and questions. Of the 40 minutes available for clinical papers, approximately 15 minutes are recommended for the problem statement, allowing 25 minutes for panel discussion. Invited presentations are 45 minutes.